New Tool Helps Patients Track Generic Drug Safety

For 20 years, Oregon psychiatrist James Hancey kept a secret list of generic drugs he suspected were unsafe after patients reported identical problems with certain medications. Now he has a powerful new tool to confirm his instincts.

ProPublica launched Rx Inspector last month, a free searchable database that traces nearly 40,000 generic medications back to their manufacturers and factory safety records. It's the first time this information has been easily available to the public.

The tool is already changing lives. John Beeler, a father of three in Atlanta, used it to investigate a generic antidepressant that gave him mysterious headaches and rashes. After two exhausting weeks of worry, he finally found answers about where his pills came from and whether others had similar problems.

The FDA has always known where generic drugs are made and which factories have safety violations, but the agency never made this information easy for the public to access. ProPublica obtained the records by suing the FDA in federal court.

Researchers say the tool is accelerating their work. John Gray, a professor at Ohio State University, is developing a quality score for generic drugs to help government programs like Medicare buy medications based on safety, not just cost. Rx Inspector has helped his team move much faster.

Health care workers are checking factory records before writing prescriptions. Hancey shared the tool with residents at his hospital so they can develop their own safety guidelines. "Experience has taught me that not all generics are the same," he said. "This will cut down on a lot of the legwork."

The timing matters because 90% of prescriptions in the United States are for generics, many made overseas. For years, pharmacists and lawmakers asked the FDA to require manufacturers to identify themselves on pill bottles, but the agency resisted.

The Ripple Effect

Col. Vic Suarez, a retired Army medical supply commander, is using Rx Inspector to help new U.S.-based drug companies produce high-quality medications. His research could strengthen domestic drug manufacturing and improve safety standards across the industry.

ProPublica published the underlying data on GitHub so other journalists and researchers can build on the work. Dozens of patients have already used the tool to investigate their own medications, describing feeling empowered after learning the truth about their pills.

Better information leads to better choices for everyone.